Skip to main content
Sai Life Sciences Limited logo

Sai Life Sciences Limited — Investor Relations & Filings

Ticker · SAILIFE ISIN · INE570L01029 LEI · 335800JBS3NY25NIBC93 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 233 across all filing types
Latest filing 2025-10-08 Regulatory Filings
Country IN India
Listing BSE.NS SAILIFE

About Sai Life Sciences Limited

https://www.sailife.com

Sai Life Sciences Limited is a full-service Contract Research, Development, and Manufacturing Organization (CRO-CDMO) that partners with global pharmaceutical and biotechnology innovators to accelerate the discovery, development, and commercialization of complex small molecules. The company provides an integrated platform of services spanning discovery chemistry and biology, DMPK, toxicology, process development, analytical R&D, and commercial-scale manufacturing. With a focus on operational excellence and regulatory compliance, it operates state-of-the-art R&D and manufacturing facilities. Its value proposition centers on the Sai Nxt initiative, which emphasizes investments in advanced technologies, expanded capacity, and a global delivery model designed to reduce time-to-market for novel therapeutics.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing a strategic partnership between Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions. It is addressed to stock exchanges and references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content focuses on the launch of an Integrated CMC Partnership to accelerate drug development, including quotes from CEOs and descriptions of the partnership benefits. There are no financial statements, regulatory filings, voting results, or management changes. The document is a communication of a corporate event rather than a financial report or regulatory filing. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-10-08 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate submitted under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2025. It is a compliance certificate from the Registrar and Share Transfer Agent certifying that details of securities dematerialized/rematerialized have been furnished to stock exchanges. The document is short (3776 characters) and serves as a regulatory compliance filing rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is not an announcement of a report but a certificate submission. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance documents.
2025-10-07 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the closure of the trading window for insiders due to upcoming financial results. It references the Securities and Exchange Board of India regulations and mentions the upcoming declaration of unaudited financial results for the second quarter and half year ending 30 September 2025. The document does not contain any financial data or results itself, nor does it include a report or detailed financial statements. It is a regulatory announcement related to insider trading restrictions ahead of financial results. The document length is short (2303 characters), and it serves as an intimation rather than a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-09-29 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is an official communication addressed to stock exchanges (NSE and BSE) regarding a revision in the intimation under Regulation 30 of SEBI (LODR) Regulations, 2015. It concerns the allotment of equity shares upon exercise of Employee Stock Options (ESOPs) under two specific plans: MESOP 2018 and ESOP 2008. The document includes detailed annexures providing regulatory disclosures required under SEBI regulations related to share allotment, pricing, number of shares issued, and other compliance details. The content is focused on notifying and revising the details of share allotment under employee stock option plans, which is a capital change event. It is not a full financial report, earnings release, or management discussion, but a regulatory intimation about share allotment. Therefore, the appropriate classification is a Share Issue/Capital Change announcement (SHA). The document length and detail confirm it is not a mere report publication announcement or a short notice, but a substantive regulatory filing about capital changes.
2025-09-19 English
Press Release
Regulatory Filings Classification · 95% confidence The document is an announcement dated 18 September 2025 from Sai Life Sciences Limited addressed to stock exchanges (NSE and BSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the opening of a new dedicated facility for veterinary API production. The content is a corporate update about operational expansion and does not contain financial statements, audit information, voting results, or any regulatory filings beyond the disclosure requirement. It is not a report, transcript, or detailed financial document but a regulatory announcement about a material event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-09-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges (BSE and NSE) about the schedule of a meeting with analysts and investors. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30 related to disclosure of events. The content is an announcement of an upcoming investor meeting rather than a report, transcript, or financial statement. The document length is short (2183 characters), and it does not contain financial data or detailed analysis. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2025-09-17 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.